Policy Updates Medical Policy & Clinical GuidelinesMedicaidMarch 18, 2024

Clinical Criteria updates — December 2023

Summary: On December 11, 2023, and January 5, 2024, the Pharmacy and Therapeutic (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem. These policies were developed, revised, or reviewed to support clinical coding edits.

Visit Clinical Criteria to search for specific policies. If you have questions or need additional information, use this email.

Please see the explanation/definition for each category of Clinical Criteria below:

  • New: newly published criteria
  • Revised: addition or removal of medical necessity requirements, new document number
  • Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive

Please share this notice with other providers in your practice and office staff.

Please note:

  • The Clinical Criteria listed below applies only to the medical drug benefits contained within the member’s medical policy. This does not apply to pharmacy services.
  • This notice is meant to inform the provider of new or revised criteria that has been adopted by Anthem only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice.

Effective date

Clinical Criteria number

Clinical Criteria title

New or revised

June 17, 2024

*CC-0255

Loqtorzi (toripalimab-tpzi)

New

June 17, 2024

*CC-0256

Rivfloza (nedosiran)

New

June 17, 2024

*CC-0257

Wainua (eplontersen)

New

June 17, 2024

*CC-0185

Oxlumo (lumasiran)

Revised

June 17, 2024

*CC-0107

Bevacizumab for Non-ophthalmologic Indications

Revised

June 17, 2024

*CC-0002

Colony Stimulating Factor Agents

Revised

June 17, 2024

CC-0075

Rituximab Agents for Non-Oncologic Indications

Revised

June 17, 2024

CC-0213

Voxzogo (vosoritide)

Revised

June 17, 2024

CC-0124

Keytruda (pembrolizumab)

Revised

June 17, 2024

*CC-0110

Perjeta (pertuzumab)

Revised

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

CABC-CD-051275-24-CPN50531

PUBLICATIONS: April 2024 Provider Newsletter